The Medicines Company (NASDAQ:MDCO)
| CAPS Rating |
|
|---|---|
| Open | $21.02 |
| Previous Close | $20.99 |
| Daily Range | $20.65 - $21.02 |
| 52-Week Range | $12.33 - $22.48 |
| Market Cap | $1.12B |
| P/E Ratio | 8.20 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 610,157 |
| Average Daily Volume | 0 |
How do you think MDCO will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MDCO Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MDCO News and Commentary
- Medicines Co. Settles with APP - Analyst Blog – NASDAQ
- Why The Medicines Co. May Be About to Take Off – The Motley Fool
- Here's What George Soros Has Been Buying and Selling – The Motley Fool
- Medicines Co. Shares Soared: What You Need to Know – The Motley Fool
- The 20 Fastest Growers in Pharma – The Motley Fool
- A New, Easy Way to Use the Magic Formula – The Motley Fool
- Rocket Stock or Dud? – The Motley Fool
- Top Pharma Stocks That Hedge Funds Love – SeekingAlpha
- Value Ideas: Undervalued Stocks With Conservative Accounting Practices – SeekingAlpha
- Why We're Positive on The Medicines Co. – SeekingAlpha
- 25 Oversold Stocks With Bearish Options Sentiment – SeekingAlpha
- Medicines CEO Discusses Q3 2010 Results - Earnings Call Transcript – SeekingAlpha
- Medicines CEO Discusses Q3 2010 Results - Earnings Call Transcript – SeekingAlpha Transcripts
- Insiders Snapping Up Take-Two Interactive, Icahn Enterprises and More – BloggingStocks
- Insiders Snapping Up Trius Therapeutics, Medicines Co and More – BloggingStocks
- Wall Street Breakfast: Must-Know News – SeekingAlpha
- The Medicines Company, Inc Q2 2010 Earnings Call Transcript – SeekingAlpha
- The Medicines Company, Inc Q2 2010 Earnings Call Transcript – SeekingAlpha Transcripts
- Biotech: Update on Deals, Mergers, Funding – SeekingAlpha
- UPDATE 1-Medicines Co Q1 profit beats estimates – Reuters

RSS Headlines
Fool UK